Editorial: New opportunities in drug design for the management and treatment of type 2 diabetes

dc.creator	Rasouli, Hassan
dc.creator	Ramalho, Teodorico C.
dc.creator	Popović-Djordjević, Jelena B.
dc.creator	Devkota, Hari Prasad
dc.date.accessioned	2023-05-05T08:03:52Z
dc.date.available	2023-05-05T08:03:52Z
dc.date.issued	2023
dc.identifier.issn	1663-9812
dc.identifier.uri	http://aspace.agrif.bg.ac.rs/handle/123456789/6335
dc.language	English
dc.rights	openAccess
dc.rights.uri	https://creativecommons.org/licenses/by/4.0/
dc.source	Frontiers in Pharmacology
dc.source	Frontiers in Pharmacology
dc.subject	diabetes mellitus
dc.subject	drug design
dc.subject	hypoglycemic agents
dc.subject	inhibitor
dc.subject	type 2 diabetes
dc.title	Editorial: New opportunities in drug design for the management and treatment of type 2 diabetes
dc.type	article	en
dc.rights.license	BY
dc.citation.rank	M21~
dc.citation.volume	14
dc.identifier.doi	10.3389/fphar.2023.1187057
dc.identifier.fulltext	http://aspace.agrif.bg.ac.rs/bitstream/id/24536/Editorial_New_opportunities_pub_2023.pdf
dc.type.version	publishedVersion